- Home
- Research
- Funded Research
- Fellowship Program
- Research News
- Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
- A Role for Lysophosphatidic Acid and Sphingosine 1-Phosphate in the Pathogenesis of Systemic Sclerosis
- Identification of Myocardial Damage in Systemic Sclerosis: A Nuclear Cardiology Approach
- Exercise pulmonary hypertension associated with systemic sclerosis: Four distinct entities.
- Generation of Transgene-Free Lung Disease-Specific Human iPS Cells Using a Single Excisable Lentiviral Stem Cell Cassette.
- Comparative Proteomic Analysis of Serum from Patients with Systemic Sclerosis and Sclerodermatous GVHD. Evidence of Defective Function of Factor H
- Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation
- Acute Kidney Injury In Patients With Systemic Sclerosis Participating In Hematopoietic Cell Transplantation Trials In The United States
- Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis.
- Vascular remodeling in pulmonary arterial hypertension: Multiple cancer-like pathways and possible treatment modalities
- Recent advances in pulmonary fibrosis: implications for scleroderma.
- The Role of Progenitor Cells in Lung Disease Prognosis
- Registry Evaluation of Digital Ulcers in Systemic Sclerosis
- Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis.
- Cellular and molecular aspects of vascular dysfunction in systemic sclerosis
- Imatinib Promising for Refractory Pulmonary Artery Hypertension
- Cardiac complications of systemic sclerosis: recent progress in diagnosis.
- Predicting Survival in Pulmonary Arterial Hypertension. Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)
- Study Suggests Link Between Scleroderma, Cancer in Certain Patients
- Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by Iloprost
- The Vascular Microenvironment and Systemic Sclerosis
- Rare Gene Variants Associated With Rheumatoid Arthritis, Type 1 Diabetes
- Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group.
- Type I interferon system activation and association with disease manifestations in systemic sclerosis.
- Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.
- Scleroderma Renal Crisis: A Pathology Perspective
- Arresto: Blocking Fibroblasts
- Targeting ADAM17-notch signaling abrogates the development of systemic sclerosis in a murine model.
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- Actelion Introduces First Pulmonary Arterial Hypertension (PAH) Multimedia Mobile Application for Healthcare Professionals
- Scleroderma Care and Research - June 2010
- The Symptom Burden Index: Development and Initial Findings from Use with Patients with Systemic Sclerosis
- The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model
- Systemic sclerosis-associated interstitial lung disease - proposed recommendations for future randomized clinical trials.
- InterMune Weighs the Odds
- B-cell Depletion with Rituximab: A Promising Treatment for Diffuse Cutaneous Systemic Sclerosis
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
- Is dysfunction of caveolin-1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies
- Granzyme B cleavage of autoantigens in autoimmunity.
- NIAMS-Funded Scientists Find Potential Target for Fibrosis Treatment
- Animal models of systemic sclerosis: Prospects and limitations
- Creating a Pathway in IPF
- Actelion Hasn’t Seen Top of PAH
- Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.
- Antagonistic Effect of the Matricellular Signaling Protein CCN3 on TGF-β- and Wnt-Mediated Fibrillinogenesis in Systemic Sclerosis and Marfan Syndrome
- Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma
- Endothelin-1 and Systemic Sclerosis
- Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease.
- Systemic sclerosis and lupus: Points in an interferon-mediated continuum
- The Current State of Biomarkers in Systemic Sclerosis
- Prognosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma)
- Type I interferons: crucial participants in disease amplification in autoimmunity
- IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.
- Th1 transcription factor T-bet regulates the expression of Tim-3.
- Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts.
- Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.
- Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis.
- Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS group.
- Medical Mystery Pieced Together
- Arginetix: Another NO to PAH
- Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.
- H. Dietz, MD - AAAS Lecture 2009
- Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study.
- D. Kastner, MD Lecture - Fevers, Genes, and Histories: Adventures in the Genomics of Inflammation
- Rituximab: a potential therapeutic advance in scleroderma What is the evidence?
- Scleroderma Care and Research - 2009
- Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.
- Botox therapy for ischemic digits
- Autoantigens in systemic autoimmunity: critical partner in pathogenesis.
- Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.
- Bayer Schering Pharma presents positive results of phase II study with Riociguat
- Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
- Transforming growth factor β as a therapeutic
- H. Dietz, MD Lecture - Marfan syndrome and related disorders : from molecules to medicines
- Recent advances in understanding Marfan syndrome: Should we now treat surgical patients with losartan?
- Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
- Autoantibodies and Microvascular Damage Are Independent Predictive Factors for the Progression of Raynaud’s Phenomenon to Systemic Sclerosis
- Development of a Preliminary Scleroderma Gastrointestinal Tract 1.0 Quality of Life Instrument
- Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13
- Update on Indices of Disease Activity in Systemic Sclerosis
- Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
- Scleroderma Care and Research Spring 2006
- Scleroderma Care and Research Autumn 2005
- Scleroderma Care and Research Winter 2004/2005
- Scleroderma Care and Research Spring 2004
- Assessment of Damage and Activity in Systemic Sclerosis
- Scientific Advisory Board
- Bruce Alberts, PhD (Chair)
- David Botstein, PhD
- Shaun R. Coughlin, MD, PhD
- Dan Kastner, MD, PhD
- Regis B. Kelly, PhD
- Henry Metzger, MD
- Antony Rosen, MD
- William J. Rutter, PhD
- Bruce U. Wintroub, MD
- George Yancopoulos, MD, PhD
- Closing Text
- Grant Guidelines and Applications
- About Us
- History
- Board of Directors
- Scientific Advisory Board
- Bruce Alberts, PhD (Chair)
- David Botstein, PhD
- Shaun R. Coughlin, MD, PhD
- Dan Kastner, MD, PhD
- Regis B. Kelly, PhD
- Henry Metzger, MD
- Antony Rosen, MD
- William J. Rutter, PhD
- Bruce U. Wintroub, MD
- George Yancopoulos, MD, PhD
- Closing Text
- 2009 Annual Report
- SRF in the News
- Get Involved
- Cure Crew
- For Patients
- Downloads
- Contact Us
- Donate
|
|
 |
|
Sitemap
